Literature DB >> 2239130

Soluble class 1 antigens (sHLA) in CSF and serum of patients with HIV infection.

J C Alvarez-Cermeño1, C Casado, L M Villar, A Ferreira, J M Varela, M Dominguez, A Bootello, R Najera, P Gonzalez-Porque.   

Abstract

sHLA are secreted by B and T lymphocytes upon activation. These antigens are present in serum and cerebrospinal fluid (CSF). The establishment of a sHLA index, IH = (CSF sHLA/serum sHLA)/(CSF albumin/serum albumin) helped us to define that values above 9.7 reflect an intrathecal synthesis of these proteins. IH was significantly increased in a group of patients with intrathecal production of IgG against HIV-1 (HIV) and directly correlated with the synthesis of such antibodies. Therefore, IH seems to be an index of lymphocyte activation in CNS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2239130     DOI: 10.1111/j.1600-0404.1990.tb01580.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.

Authors:  B Gansuvd; M Hagihara; B Munkhbat; N Kanai; N Morita; N Munkhtuvshin; J Chargui; S Kato; T Hotta; K Tsuji
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Authors:  S Migliaresi; A Bresciani; L Ambrosone; M Spera; D Barbarulo; V Lombari; G Pirozzi; G Borgia; M L Lombardi; G Tirri; C Manzo
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

Review 3.  Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens.

Authors:  Katerina Bakela; Irene Athanassakis
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

4.  Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease.

Authors:  C Moore; M Ehlayel; J Inostroza; L E Leiva; S Kuvibidila; L Yu; R Gardner; D L Ode; R Warrier; R U Sorensen
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

5.  Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.

Authors:  Irena Adamashvili; Robert Wolf; Donnie Aultman; Edgar L Milford; Stephen Jaffe; Vicky Hall; Thomas Pressly; Alireza Minagar; Roger Kelley
Journal:  Rheumatol Int       Date:  2003-07-23       Impact factor: 2.631

6.  Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics.

Authors:  Annemijn P A Wierenga; Gülçin Gezgin; Els van Beelen; Michael Eikmans; Marijke Spruyt-Gerritse; Niels J Brouwer; Mieke Versluis; Robert M Verdijk; Sjoerd G van Duinen; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-18       Impact factor: 6.639

7.  Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.

Authors:  G Filaci; P Contini; S Brenci; P Gazzola; L Lanza; M Scudeletti; F Indiveri; G L Mancardi; F Puppo
Journal:  Hum Immunol       Date:  1997-04-15       Impact factor: 2.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.